TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 17.66

Change

+0.04 (+0.23)%

Market Cap

CAD 0.07B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.20 (+0.75%)

CAD 6.19B
CASH:CA Horizons High Interest Savings..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

+0.01 (+0.06%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.13 (+0.20%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.09 (+0.22%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.03 (-0.14%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.10 (+0.34%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.11%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

-0.08 (-0.57%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.03 (+0.14%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.20% 46% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.20% 45% F 41% F
Trailing 12 Months  
Capital Gain 0.40% 32% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.40% 28% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.90% 63% D 51% F
Dividend Return 1.90% 62% D 45% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.27% 73% C 87% B+
Risk Adjusted Return 35.99% 73% C 63% D
Market Capitalization 0.07B 58% F 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike